Founder & CSO Kate Rosenbluth was recognized by Fortune Magazine as one of the most influential people of 2020 for her dedication to transforming the standard of care for chronic disease.
21-year U.S. Air Force Veteran Ben shares how Cala Trio reduced his tremors significantly and renewed hope to live a nearly normal life after 10 years of tremors.
March is Essential Tremor Awareness Month. Holly shares her journey with essential tremor, which is unique, just like every person living with this condition.
Dr. Salima Brillman, a movement disorder specialist, answers questions about essential tremors and COVID-19.
Ben, Air Force veteran of 21 years, tried Cala Trio to treat his essential tremor.
New data presented Monday at the Virtual ISPOR Europe 2020 conference underscore the growing prevalence of essential tremor and the need for devices like the Cala Trio.
Dr. Rohit Dhall, MD, Associate Professor of Neurology and Director of Neurodegenerative Disorders at the University of Arkansas discusses essential tremors (ET) and a new wrist-worn bioelectronic device, called the Cala Trio™
Cala Health was nominated as the Best Medical Technology by Prix Galien USA for Cala Trio™, the first non-invasive targeted therapy that reduces hand tremors for adults living with essential tremor (ET).
Cala Health has developed a product to treat a massive unmet need in medicine. In the United States, it’s estimated that 2.2% of the population suffers from essential tremor (ET). This condition, much like Parkinson’s Disease, causes involuntary sharking, particularly in the hands, but ET is much more widespread.
It’s a watch-like device that stimulates nerves in the wrist to interrupt, and therefore, calm tremors in the hands. Listen to this conversation about the Cala Trio from Cala Health CEO Renee Ryan.
Cala Trio by Cala Health took the gold award for the Medical Device/ Dental: Diagnostics and Disease Treatment category.